|
1
|
Bou Kheir T, Futoma-Kazmierczak E,
Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B,
Lund AH and Friis-Hansen L: miR-449 inhibits cell proliferation and
is down-regulated in gastric cancer. Mol Cancer. 10:292011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fock KM and Ang TL: Epidemiology of
Helicobacter pylori infection and gastric cancer in Asia. J
Gastroenterol Hepatol. 25:479–486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh
KG, Goh KL, Wu KC, Wu DC, Sollano J, Kachintorn U, et al: Screening
for gastric cancer in Asia: Current evidence and practice. Lancet
Oncol. 9:279–287. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cunningham D and Chua YJ: East meets west
in the treatment of gastric cancer. N Engl J Med. 357:1863–1865.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yilmaz M and Christofori G: Mechanisms of
motility in metastasizing cells. Mol Cancer Res. 8:629–642. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vignot S and Soria JC: Discrepancies
between primary tumor and metastasis: Impact on personalized
medicine. Bull Cancer. 100:561–568. 2013.In French. PubMed/NCBI
|
|
8
|
Wang J, Shi YK, Wu LY, Wang JW, Yang S,
Yang JL, Zhang HZ and Liu SM: Prognostic factors for ovarian
metastases from primary gastric cancer. Int J Gynecol Cancer.
18:825–832. 2008. View Article : Google Scholar
|
|
9
|
Bianco P, Robey PG and Simmons PJ:
Mesenchymal stem cells: Revisiting history, concepts and assays.
Cell Stem Cell. 2:313–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kato N, Hayasaka T, Takeda J, Osakabe M
and Kurachi H: Ovarian tumors with functioning stroma: A
clinicopathologic study with special reference to serum estrogen
level, stromal morphology and aromatase expression. Int J Gynecol
Pathol. 32:556–561. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Calloni R, Cordero EA, Henriques JA and
Bonatto D: Reviewing and updating the major molecular markers for
stem cells. Stem Cells Dev. 22:1455–1476. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Droujinine IA, Eckert MA and Zhao W: To
grab the stroma by the horns: From biology to cancer therapy with
mesenchymal stem cells. Oncotarget. 4:651–664. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cuiffo BG and Karnoub AE: Mesenchymal stem
cells in tumor development: Emerging roles and concepts. Cell Adh
Migr. 6:220–230. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang X, Hou J, Han Z, Wang Y, Hao C, Wei L
and Shi Y: One cell, multiple roles: Contribution of mesenchymal
stem cells to tumor development in tumor microenvironment. Cell
Biosci. 3:52013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu MH, Gao X, Luo D, Zhou XD, Xiong W and
Liu GX: EMT and acquisition of stem cell-like properties are
involved in spontaneous formation of tumorigenic hybrids between
lung cancer and bone marrow-derived mesenchymal stem cells. PLoS
One. 9:e878932014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ono M, Kosaka N, Tominaga N, Yoshioka Y,
Takeshita F, Takahashi RU, Yoshida M, Tsuda H, Tamura K and Ochiya
T: Exosomes from bone marrow mesenchymal stem cells contain a
microRNA that promotes dormancy in metastatic breast cancer cells.
Sci Signal. 7:ra632014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sung SY, Liao CH, Wu HP, Hsiao WC, Wu IH,
Jinpu Yu, Lin SH and Hsieh CL: Loss of let-7 microRNA upregulates
IL-6 in bone marrow-derived mesenchymal stem cells triggering a
reactive stromal response to prostate cancer. PLoS One.
8:e716372013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Konno Y, Dong P, Xiong Y, Suzuki F, Lu J,
Cai M, Watari H, Mitamura T, Hosaka M, Hanley SJ, et al:
MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation,
invasion and stem cell-like phenotype of aggressive endometrial
cancer cells. Oncotarget. 5:6049–6062. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu Z, Jiang Z, Huang J, Huang S, Li Y,
Sheng F, Yu S, Yu S and Liu X: Mesenchymal stem cells show little
tropism for the resting and differentiated cancer stem cell-like
glioma cells. Int J Oncol. 44:1223–1232. 2014.PubMed/NCBI
|
|
20
|
Ochs K, Sahm F, Opitz CA, Lanz TV, Oezen
I, Couraud PO, von Deimling A, Wick W and Platten M: Immature
mesenchymal stem cell-like pericytes as mediators of
immunosuppression in human malignant glioma. J Neuroimmunol.
265:106–116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bian ZY, Li G, Gan YK, Hao YQ, Xu WT and
Tang TT: Increased number of mesenchymal stem cell-like cells in
peripheral blood of patients with bone sarcomas. Arch Med Res.
40:163–168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kirkland SC: Type I collagen inhibits
differentiation and promotes a stem cell-like phenotype in human
colorectal carcinoma cells. Br J Cancer. 101:320–326. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marrelli M, Paduano F and Tatullo M: Cells
isolated from human periapical cysts express mesenchymal stem
cell-like properties. Int J Biol Sci. 9:1070–1078. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao H, Xu W, Qian H, Zhu W, Yan Y, Zhou H,
Zhang X and Xu X, Li J, Chen Z and Xu X: Mesenchymal stem cell-like
cells derived from human gastric cancer tissues. Cancer Lett.
274:61–71. 2009. View Article : Google Scholar
|
|
25
|
Mamidi MK, Pal R, Govindasamy V, Zakaria Z
and Bhonde R: Treat the graft to improve the regenerative ability
of the host. Med Hypotheses. 76:599–601. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu J, Wang W, Kapila Y, Lotz J and Kapila
S: Multiple differentiation capacity of
STRO-1+/CD146+ PDL mesenchymal progenitor
cells. Stem Cells Dev. 18:487–496. 2009. View Article : Google Scholar :
|
|
27
|
Ribitsch I, Burk J, Delling U, Geißler C,
Gittel C, Jülke H and Brehm W: Basic science and clinical
application of stem cells in veterinary medicine. Adv Biochem Eng
Biotechnol. 123:219–263. 2010.PubMed/NCBI
|
|
28
|
Dezawa M, Ishikawa H, Itokazu Y, Yoshihara
T, Hoshino M, Takeda S, Ide C and Nabeshima Y: Bone marrow stromal
cells generate muscle cells and repair muscle degeneration.
Science. 309:314–317. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Barberini DJ, Freitas NP, Magnoni MS, Maia
L, Listoni AJ, Heckler MC, Sudano MJ, Golim MA, da Cruz
Landim-Alvarenga F and Amorim RM: Equine mesenchymal stem cells
from bone marrow, adipose tissue and umbilical cord:
Immunophenotypic characterization and differentiation potential.
Stem Cell Res Ther. 5:252014. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cuiffo BG and Karnoub AE: Mesenchymal stem
cells in tumor development: Emerging roles and concepts. Cell Adh
Migr. 6:220–230. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thirant C, Bessette B, Varlet P, Puget S,
Cadusseau J, Tavares Sdos R, Studler JM, Silvestre DC, Susini A,
Villa C, et al: Clinical relevance of tumor cells with stem-like
properties in pediatric brain tumors. PLoS One. 6:e163752011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kaplan RN, Riba RD, Zacharoulis S, Bramley
AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et
al: VEGFR1-positive haematopoietic bone marrow progenitors initiate
the pre-metastatic niche. Nature. 438:820–827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lescarbeau RM, Seib FP, Prewitz M, Werner
C and Kaplan DL: In vitro model of metastasis to bone marrow
mediates prostate cancer castration resistant growth through
paracrine and extracellular matrix factors. PLoS One. 7:e403722012.
View Article : Google Scholar : PubMed/NCBI
|
